Indivi develops functional biomarkers that measure key disability concepts of importance for drug development trials in neuroscience
Indivi has raised $18.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Indivi's investors include Ava Investors, Lichtsteiner Foundation, Zühlke Ventures AG.
Indivi is headquartered in Basel, Switzerland.
Indivi develops functional biomarkers that measure key disability concepts of importance for drug development trials in neuroscience
Indivi is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Indivi — Funding & Investors." VCBacked, November 12, 2025, https://www.vcbacked.co/company/indivi. Accessed November 13, 2026.
VCBacked. (2025). Indivi — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/indivi
{{cite web |title=Indivi — Funding & Investors |url=https://www.vcbacked.co/company/indivi |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Indivi? Request a listing update